Case of fertility treatment-induced Stevens-Johnson syndrome with a severe ocular complication.
Adult
Anti-Inflammatory Agents
/ administration & dosage
Cabergoline
/ administration & dosage
Cefdinir
/ administration & dosage
Chorionic Gonadotropin
/ administration & dosage
Clomiphene
/ administration & dosage
Drug Therapy, Combination
/ adverse effects
Eye Diseases
/ chemically induced
Female
Fertility Agents, Female
/ adverse effects
Glucocorticoids
/ administration & dosage
Humans
Infertility, Female
/ drug therapy
Medroxyprogesterone Acetate
/ administration & dosage
Plasma Exchange
Stevens-Johnson Syndrome
/ etiology
Stevens-Johnson syndrome
adverse drug reaction
infertility
keratoconjunctivitis
plasma exchange
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
22
03
2019
accepted:
08
08
2019
pubmed:
7
9
2019
medline:
14
4
2020
entrez:
7
9
2019
Statut:
ppublish
Résumé
Pharmacological regimens with multiple medications are being used in fertility treatments. Herein, we report a case of a 40-year-old Japanese woman who developed Stevens-Johnson syndrome (SJS) with a severe ocular complication during fertility treatment. Despite early multimodal interventions, including methylprednisolone pulse therapy and plasma exchange, her ocular complications persisted for more than a year. The four drugs administered in this case (cabergoline, medroxyprogesterone acetate, clomiphene, and intravenous human chorionic gonadotropin) have never been reported to induce SJS. Based on this case, we suggest that obstetricians, gynecologists, and dermatologists should be aware of fertility treatment-induced severe drug eruptions.
Identifiants
pubmed: 31489686
doi: 10.1111/1346-8138.15072
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Chorionic Gonadotropin
0
Fertility Agents, Female
0
Glucocorticoids
0
Clomiphene
1HRS458QU2
Medroxyprogesterone Acetate
C2QI4IOI2G
Cefdinir
CI0FAO63WC
Cabergoline
LL60K9J05T
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1042-1045Informations de copyright
© 2019 Japanese Dermatological Association.
Références
Goldman MB, Thornton KL, Ryley D et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil Steril 2014; 101: 1574-1581.
Schoolcraft W, Meseguer M, Global Fertility Alliance. Paving the way for a gold standard of care for infertility treatment: improving outcomes through standardization of laboratory procedures. Reprod Biomed Online 2017; 35: 391-399.
Aihara M, Kano Y, Fujita H et al. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis. J Dermatol 2015; 42: 768-777.
Shiohara T, Kano Y, Mizukawa Y et al. Guideline for the management of severe erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrosis. Jpn J Dermatol 2016; 126: 1637-1685 (In Japanese).
Sotozono C, Ueta M, Nakatani E et al. Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol 2015; 160: 228-237.
Sassolas B, Haddad C, Mockenhaupt M et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 2010; 88: 60-68.
Nakae M, Tamagawa-Mineoka R, Masuda K, Ueta M, Sotozono C, Katoh N. Stevens-Johnson syndrome and toxic epidermal necrolysis cases treated at our hospital over the past 10 years. J Cutan Immunol Allergy 2019; 2: 25-30.
Grunnet KM, Powell KS, Miller IA, Davis LS. Autoimmune progesterone dermatitis manifesting as mucosal erythema multiforme in the setting of HIV infection. JAAD Case Rep 2017; 3: 22-24.
Drayer SM, Laufer LR, Farrell ME. Autoimmune progesterone dermatitis mistaken for Stevens-Johnson syndrome. Obstet Gynecol 2018; 131: 723-726.
Jenkins J, Geng A, Robinson-Bostom L. Autoimmune progesterone dermatitis associated with infertility treatment. J Am Acad Dermatol 2008; 58: 353-355.
James T, Ghaferi J, LaFond A. The histopathologic features of autoimmune progesterone dermatitis. J Cutan Pathol 2017; 44: 70-74.
Ueta M, Tokunaga K, Sotozono C et al. HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens-Johnson syndrome with severe ocular surface complications. PLoS ONE 2012; 7: e43650.
Ueta M. Results of detailed investigations into Stevens-Johnson syndrome with severe ocular complications. Invest Ophthalmol Vis Sci 2018; 59: DES183-DES191.
Kannabiran C, Ueta M, Sangwan V et al. Association of human leukocyte antigen class 1 genes with Stevens Johnson syndrome with severe ocular complications in an Indian population. Sci Rep 2017; 7: 15960.